Department of Ageing and Health, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Institute of Pharmaceutical Science, King's College London, London, UK.
Br J Clin Pharmacol. 2022 Oct;88(10):4595-4606. doi: 10.1111/bcp.15386. Epub 2022 May 26.
Sixty-four million pharmacy-filled multicompartment medication compliance aids (MCAs) are dispensed by pharmacies in England each year. Despite the widespread use of MCAs and evidence that their use may be associated with harm there is no national consensus regarding MCA provision by acute hospital Trusts in England. The aim was to determine current practice for initiation and supply of MCAs in acute hospital Trusts in England and the potential consequences for patients and hospitals.
A 26-item survey was distributed to all acute hospital Trusts in England. The questionnaire covered: policy, initiation, supply and review of MCAs; alternatives offered; and pharmacy staffing and capacity related to MCAs.
Seventy-two out of 138 (52%) Trusts responded to the survey: 70 Trusts responded regarding policy for MCA provision, with 60 (86%) having a policy regarding this; 33/55 (60%) that supplied MCAs on discharge supplied a different prescription length for MCA vs. non-MCA prescriptions; 49/55 (89%) Trusts provided only 1 brand of MCA; 47/55 (85%) MCA-supplying Trusts identified frequent difficulties with MCAs and 13/55 (24%) reported employing staff specifically to complete MCAs; and 30/35 (86%) MCA-initiating Trusts had an assessment process for initiation, with care agency request reportedly the most common reason for initiation.
There is a lack of a national approach to MCA provision and initiation by acute hospital Trusts in England. This leads to significant variation in care and has the potential to put MCA users at an increased risk of medication-related harm.
英格兰的药店每年分发 6400 万份多室药物依从性辅助器(MCA)。尽管 MCA 被广泛使用,并且有证据表明其使用可能与危害有关,但英格兰急性医院信托机构在 MCA 供应方面尚未达成全国共识。目的是确定英格兰急性医院信托机构开始和供应 MCA 的现行做法,以及对患者和医院的潜在影响。
向英格兰所有急性医院信托机构分发了一份 26 项的调查问卷。问卷涵盖:MCA 的启动、供应和审查政策;提供的替代方案;与 MCA 相关的药剂师人员配备和能力。
138 家信托机构中有 72 家(52%)回应了调查:70 家信托机构对 MCA 供应政策做出了回应,其中 60 家(86%)有相关政策;33/55(60%)在出院时供应 MCA 的机构为 MCA 与非 MCA 处方提供了不同的处方长度;49/55(89%)信托机构仅提供 1 种 MCA 品牌;47/55(85%)供应 MCA 的信托机构发现 MCA 经常出现问题,13/55(24%)报告专门雇佣员工来完成 MCA;30/35(86%)启动 MCA 的信托机构有启动评估流程,据报道,机构护理的请求是启动的最常见原因。
英格兰急性医院信托机构在 MCA 供应和启动方面缺乏全国性方法。这导致护理方面存在显著差异,并有可能使 MCA 用户面临增加的药物相关伤害风险。